Cost-effectiveness of budesonide Turbuhaler in the treatment of mild-to-moderate asthma in Japan

スポンサーリンク

概要

• 論文の詳細を見る
• 1999-12-01

著者

• MIYAMOTO Terumasa

  Japan Clinical Allergy Research Institute

• Nakajima Shigenori

  Life Science Center Kinki University

• Nakajima Shigenori

  Life Science Institute Kinki University School Of Medicine

• FUJINO Shiro

  Faculty of Economics, Chuo University

• TOLLEMAR Ulf

  Astra Japan Ltd

• LILJAS Bengt

  Astra Pharmaceuticals

• Fujino Shiro

  Faculty Of Economics Chuo University

• Miyamoto Terumasa

  Japan Allergy Clinical Research Institute

関連論文

• Peak expiratory flow in normal healthy Japanese adults : Comparisons with values reported in other races
• Identifying Predictors of Response to Suplatast Tosilate among Patients with Moderate to Severe Bronchial Asthma Receiving Inhaled Steroid Therapy
• Analysis of the Risk-factors for Post-traumatic Stress Disorder in the Victims of Hanshin-Awaji Earthquake
• The Role of Cytokines in the Pathogenesis of Bronchial Asthma
• A basic policy for allergen standerdization in our country and standardization of Japanese cedar (Cryptomeria japonica) pollen extracts
• Effect of Transdermal Tulobuterol Added to Inhaled Corticosteroids in Asthma Patients
• Cost-effectiveness of budesonide Turbuhaler in the treatment of mild-to-moderate asthma in Japan
• One Year Treatment with Omalizumab Is Effective and Well Tolerated in Japanese Patients with Moderate-to-Severe Persistent Asthma

スポンサーリンク